We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$56.4M
AUM Growth
-$123M
(-69%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-227.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
19
New
–
Increased
–
Reduced
1
Closed
14
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$12.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$11M |
| 3 |
Toyota
TM
|
+$10.9M |
| 4 |
Dynatrace
DT
|
+$10.6M |
| 5 |
Mastercard
MA
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 77.3% |
| 2 | Industrials | 20.23% |
| 3 | Financials | 0% |
| 4 | Communication Services | 0% |
| 5 | Real Estate | 0% |
Similar funds
VM
SSC
I
ACM
MCM
MIA
SP
TI
Howard Hughes Medical Institute's Q1 2023 Portfolio in Review
As of Q1 2023, Howard Hughes Medical Institute held 19 positions worth $56.4M, down 69% from $180M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Howard Hughes Medical Institute withdrew a net $128M in Q1 2023, closing 14 positions and reducing 1 holding. Its most notable exit was Deere & Co, an estimated $12.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 77% of assets, up from 36% a quarter earlier, followed by Industrials and Financials.
- Howard Hughes Medical Institute's biggest Q1 2023 reduction was Dynatrace, cutting an estimated $10.6M.
- Howard Hughes Medical Institute fully exited Deere & Co in Q1 2023, selling an estimated $12.9M.
- Howard Hughes Medical Institute's ten largest holdings make up 100% of its $56.4M portfolio in Q1 2023.
- Howard Hughes Medical Institute opened 0 new positions and closed 14 in Q1 2023.
- Howard Hughes Medical Institute's portfolio value fell 69% quarter-over-quarter to $56.4M.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2023, filed 15 May 2023.